|
Comorbidity
|
DSG (N = 62)
|
NDSG (N = 433)
|
p value
|
|---|
|
Hypertension
|
41 (66.1)
|
265 (61.2)
|
0.52
|
|
Diabetes
|
19 (30.6)
|
89 (20.6)
|
0.07
|
|
Ischemic Heart Disease
|
5 (8.1)
|
58 (13.4)
|
0.23
|
|
Heart Failure
|
1 (1.6)
|
55 (12.7)
|
0.009
|
|
Chronic Kidney Disease (III-IV-V stage)
|
8 (12.9)
|
55 (12.7)
|
1.00
|
|
Stroke or TIA
|
9 (14.5)
|
52 (12.0)
|
0.84
|
|
PCOA
|
5 (8.1)
|
23 (5.3)
|
0.38
|
|
COPD
|
0 (0)
|
45 (10.4)
|
0.008
|
|
Hepatic Steatosis
|
3 (4.8)
|
9 (2.1)
|
0.19
|
|
End-stage Liver Disease
|
2 (3.2)
|
6 (1.4)
|
0.29
|
|
Localized or Hematological Cancer
|
15 (24.2)
|
70 (16.2)
|
0.13
|
|
Metastatic Cancer
|
6 (9.7)
|
21 (4.8)
|
0.12
|
- All data are expressed with number of cases (%)
- DGS Digestive Symptoms group, NDGS No Digestive Symptoms Group, TIA Transitory Ischemic Attack, PCOA Peripheral Chronic Obstructive Arteriopathy, COPD Chronic Obstructive Pulmonary Disease
